
India’s drug safety deficit: critical gaps in an overly complex system need urgent remedies Premium
The Hindu
India's pharmaceutical industry success story is marred by regulatory gaps, quality issues, and a trust deficit, threatening its global reputation.
More Related News

Climate scientists and advocates long held an optimistic belief that once impacts became undeniable, people and governments would act. This overestimated our collective response capacity while underestimating our psychological tendency to normalise, says Rachit Dubey, assistant professor at the department of communication, University of California.





